- Home
- RSSS vs ONCY Comparison
RSSS vs ONCY Comparison
Compare RSSS & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSSS
- ONCY
- Stock Information
- Founded
- RSSS 2006
- ONCY 1998
- Country
- RSSS United States
- ONCY Canada
- Employees
- RSSS N/A
- ONCY N/A
- Industry
- RSSS Business Services
- ONCY Pharmaceuticals and Biotechnology
- Sector
- RSSS Consumer Discretionary
- ONCY Health Care
- Exchange
- RSSS Nasdaq
- ONCY Nasdaq
- Market Cap
- RSSS 90.6M
- ONCY 89.7M
- IPO Year
- RSSS N/A
- ONCY 1999
- Fundamental
- Price
- RSSS $2.71
- ONCY $1.12
- Analyst Decision
- RSSS
- ONCY Strong Buy
- Analyst Count
- RSSS 0
- ONCY 4
- Target Price
- RSSS N/A
- ONCY $4.33
- AVG Volume (30 Days)
- RSSS 39.7K
- ONCY 1.5M
- Earning Date
- RSSS 05-08-2025
- ONCY 07-31-2025
- Dividend Yield
- RSSS N/A
- ONCY N/A
- EPS Growth
- RSSS N/A
- ONCY N/A
- EPS
- RSSS N/A
- ONCY N/A
- Revenue
- RSSS $48,753,578.00
- ONCY N/A
- Revenue This Year
- RSSS $12.42
- ONCY N/A
- Revenue Next Year
- RSSS $7.47
- ONCY N/A
- P/E Ratio
- RSSS N/A
- ONCY N/A
- Revenue Growth
- RSSS 14.85
- ONCY N/A
- 52 Week Low
- RSSS $2.32
- ONCY $0.33
- 52 Week High
- RSSS $4.24
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- RSSS 43.64
- ONCY 75.21
- Support Level
- RSSS $2.71
- ONCY $1.04
- Resistance Level
- RSSS $3.10
- ONCY $1.23
- Average True Range (ATR)
- RSSS 0.09
- ONCY 0.12
- MACD
- RSSS -0.01
- ONCY 0.03
- Stochastic Oscillator
- RSSS 14.10
- ONCY 81.62
About RSSS Research Solutions Inc
Research Solutions Inc is a holding company. The company provides a cloud-based SaaS research intelligence platform consisting of proprietary software and Internet-based interfaces. Its platform also allows customers to find and download digital versions of STM articles. Platforms and Transactions are packaged as a single solution that enables life science and other research-intensive organizations to speed up research and development activities. The company platform allows customers to initiate orders, manage transactions, automate authentication, obtain reports, and connect seamlessly to corporate intranets.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.